European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Market report

Respiratory drug tenders in Portugal — market report, May 2025

Respiratory drug tenders in Portugal in May 2025: 80 tenders published (+78% month on month, +196% year on year), estimated at €1,925,820 in total, and 63 contracts awarded (+13% month on month, +163% year on year), worth €2,682,588 (contract value). Buyers with the most tenders: Unidade Local de Saúde de Matosinhos, EPE (ULSM) (10), Unidade Local de Saúde do Oeste, EPE (9) and Unidade Local de Saúde do Alto Ave, E. P. E. (7); most contracts won: Ipsen Portugal-Produtos Farmacêuticos Sa. (13), Glaxosmithkline-Prod. Farmacêuticos, Lda. (9) and Generis – Farmaceutica, S.A. (8). On average 13.0 bids per contract; 0% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
80
Contracts awarded
63
Contract value contract
€2,682,588
Bids per contract
13.0
Tenders published per month
020406080May 24: 27May 24: 27May 24Jun 24: 19Jun 24: 19Jun 24Jul 24: —Jul 24Aug 24: 12Aug 24: 12Aug 24Sep 24: —Sep 24Oct 24: —Oct 24Nov 24: 10Nov 24: 10Nov 24Dec 24: 32Dec 24: 32Dec 24Jan 25: 69Jan 25: 69Jan 25Feb 25: 36Feb 25: 36Feb 25Mar 25: 23Mar 25: 23Mar 25Apr 25: 45Apr 25: 45Apr 25May 25: 80May 25: 8080May 25
Contracts awarded per month
020406080May 24: 24May 24: 24May 24Jun 24: 16Jun 24: 16Jun 24Jul 24: —Jul 24Aug 24: 12Aug 24: 12Aug 24Sep 24: —Sep 24Oct 24: —Oct 24Nov 24: 10Nov 24: 10Nov 24Dec 24: 50Dec 24: 50Dec 24Jan 25: 59Jan 25: 59Jan 25Feb 25: 39Feb 25: 39Feb 25Mar 25: 31Mar 25: 31Mar 25Apr 25: 56Apr 25: 56Apr 25May 25: 63May 25: 6363May 25

The highlighted bar is May 2025. Hover a bar for its figure; the table below has every value.

FigureMay 2025April 2025ChangeMay 2024Change
Tenders published8045+78%27+196%
Estimated value€1,925,820€14,658,283-87%€2,235,506-14%
Buyers2211+100%4+450%
Contracts awarded6356+13%24+163%
Contract value (contract)€2,682,588€4,951,858-46%€969,037+177%
Winners17170%14+21%
Bids per contract13.011.8———
Single-bid contracts0%0%———

Buyers with the most tenders

Companies with the most contracts

Where the tenders were

  • Grande Lisboa 2

Procedures

  • not stated 78
  • Restricted procedure 2

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Respiratory drugs and antihistamines

Questions and answers

How many respiratory drug tenders were published in Portugal in May 2025?
80 (by 22 buyers); for comparison, April 2025: 45, May 2024: 27.
Who won the most respiratory drug tenders in Portugal in May 2025?
By number of contracts: Ipsen Portugal-Produtos Farmacêuticos Sa. (13), Glaxosmithkline-Prod. Farmacêuticos, Lda. (9), Generis – Farmaceutica, S.A. (8), Astrazeneca-Produtos Farmacêuticos,lda. (3) and Labesfal-Lab. Almiro, Sa. (3); 17 companies won contracts in all.
Which buyers published the most respiratory drug tenders in May 2025?
Unidade Local de Saúde de Matosinhos, EPE (ULSM) (10), Unidade Local de Saúde do Oeste, EPE (9), Unidade Local de Saúde do Alto Ave, E. P. E. (7), Unidade Local de Saúde do Alto Alentejo, E. P. E. (5) and Unidade Local de Saúde de Lisboa Ocidental, E. P. E. (4).
How competitive were respiratory drug tenders in Portugal in May 2025?
On average 13.0 bids per contract (10 contracts with a known number of bids); 0% of contracts had a single bid.
What were the contracts worth in May 2025?
€2,682,588 (contract value, 63 contracts); median about €2,600.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.